Assyro AI

FDA Orange Book · active-ingredient family

Calcium chloride; potassium chloride; sodium chloride

Calcium chloride; potassium chloride; sodium chloride is approved in 8 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

8

Brand (NDA)

0

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · injectable, solution

ProductApplicantApplicationTEApproved
RINGER'S IN PLASTIC CONTAINERB BRAUNNDA 020002APApr 17, 1992
RINGER'S IN PLASTIC CONTAINERB BRAUNNDA 018721Nov 09, 1982
RINGER'S IN PLASTIC CONTAINERBAXTER HLTHCARENDA 018495ATFeb 19, 1982
RINGER'S IN PLASTIC CONTAINERBAXTER HLTHCARENDA 016693APApproved Prior to Jan 1, 1982
RINGER'S IN PLASTIC CONTAINEROTSUKA ICU MEDCLNDA 018251APApproved Prior to Jan 1, 1982
RINGER'S IN PLASTIC CONTAINERABBOTTNDA 018462Approved Prior to Jan 1, 1982
RINGER'S IN PLASTIC CONTAINERB BRAUNNDA 018156ATApproved Prior to Jan 1, 1982
RINGER'S IN PLASTIC CONTAINEROTSUKA ICU MEDCLNDA 017635ATApproved Prior to Jan 1, 1982

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Calcium chloride; potassium chloride; sodium chloride — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.